CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Ropivacaine 0.2% Injectable Solution +2 moredrug
Likely dose
Ropivacaine 0.2% Injectable Solution 5mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04665531
NCT04665531N/ACompleted

Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung Surgery

Surgery Bitenc·interventional·Posted Dec 11, 2020·Updated Jul 19, 2022

In Brief

A clinical study evaluating Erector Spinae Catheter, Intercostal block, and 1 other intervention for Neoplasm of Lung and Thoracic Surgery, Video-Assisted. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of the research is to prove the analgesic efficacy of a novel technique in regional anaesthesia, i.e. the catheter under the erector spinae muscle (ESC). Investigators will evaluate the use of the ESC for analgesia after video-assisted thoracoscopic lung surgeries in comparison to the standard method of post-operative analgesia, which is the multiple level intercostal block given at the end of surgery by the surgeon. Investigators will compare the amount of opioid analgesics required by the patient using the patient controlled pump, the pain status in 48-hours after surgery and compare the differences between pre- and post-operative main inspiratory pressure and main expiratory pressure measurements between the two research groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSlovenia
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 11, 2020
Enrollment StartFeb 19, 2020
Primary CompletionMar 14, 2022
Study CompletionJun 14, 2022
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 5.6 years ago

Interventions

Erector Spinae Catheterprocedure

Patients in the experimental group will receive the Erector Spinae Catheter with an initial bolus ob 20ml 0,5% levobupivacaine prior the surgery and will be administered local anesthetics for 48 hours post-operatively.

Intercostal blockprocedure

Patients in the comparative group will receive standard treatment, i.e. the multi-level intercostal block with 20ml 0,5% levobupivacaine administered at the end of the surgery by the surgeon.

Ropivacaine 0.2% Injectable Solutiondrug

Patients in the experimental group will receive Ropivacaine 0,2% continous infusion of 5ml/h with boluses 15ml/4h by the Erector Spinae Catheter for 48 hours post-operatively.